I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 0.9397 USD -2.01% Market Closed
Market Cap: 76m USD
Have any thoughts about
I-Mab?
Write Note

I-Mab
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

I-Mab
Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
I-Mab
NASDAQ:IMAB
Operating Expenses
-ÂĄ1.3B
CAGR 3-Years
3%
CAGR 5-Years
-21%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Operating Expenses
-ÂĄ23.5B
CAGR 3-Years
-22%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Operating Expenses
-ÂĄ3.1B
CAGR 3-Years
-41%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Operating Expenses
-ÂĄ954.2m
CAGR 3-Years
-6%
CAGR 5-Years
2%
CAGR 10-Years
-19%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Operating Expenses
-ÂĄ4.6B
CAGR 3-Years
-29%
CAGR 5-Years
-28%
CAGR 10-Years
-30%
Imeik Technology Development Co Ltd
SZSE:300896
Operating Expenses
-ÂĄ649m
CAGR 3-Years
-53%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
No Stocks Found

I-Mab
Glance View

Market Cap
76m USD
Industry
Biotechnology

I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-01-17.

IMAB Intrinsic Value
0.7454 USD
Overvaluation 21%
Intrinsic Value
Price

See Also

What is I-Mab's Operating Expenses?
Operating Expenses
-1.3B CNY

Based on the financial report for Dec 31, 2023, I-Mab's Operating Expenses amounts to -1.3B CNY.

What is I-Mab's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-21%

Over the last year, the Operating Expenses growth was 27%. The average annual Operating Expenses growth rates for I-Mab have been 3% over the past three years , -21% over the past five years .

Back to Top